• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    Seattle Genetics, Inc. (SGEN)

    -NasdaqGS
    35.48 Down 1.81(4.85%) Apr 29, 4:00PM EDT
    |After Hours : 35.48 0.00 (0.00%) Apr 29, 4:55PM EDT
    Prev Close:37.29
    Open:35.75
    Bid:34.26 x 100
    Ask:39.80 x 100
    1y Target Est:44.21
    Beta:1.94278
    Earnings Date:Jul 28 - Aug 1 (Est.)
    Day's Range:35.17 - 37.49
    52wk Range:26.02 - 52.33
    Volume:1,671,861
    Avg Vol (3m):1,338,900
    Market Cap:4.97B
    P/E (ttm):N/A
    EPS (ttm):-0.93
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SGENDown 4.85%4.97B
    IMGNDown 18.93%596.37M
    PFEDown 0.61%202.54B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):15.49
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.09
    Quarterly EPS Est (Jun-16) :-0.31
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-1.87

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Seattle Genetics, Inc., a biotechnology company, develops and commercializes targeted therapies for the treatment of cancer worldwide. It markets ADCETRIS (brentuximab vedotin), an antibody-drug conjugate for the treatment of relapsed Hodgkin lymp... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback